ARCHIVES

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Cancer Survivorship: NCI Offers Training Program, video, For Health Professionals

October 24, 1997

Finally, An FY01 Appropriation For NIH; NCI’s Share $3.757 Billion, A 13.5% Raise.

January 5, 2001

New Jersey Insurers To Cover Patient Care Costs In Trials.

January 14, 2000

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006